drugset / Trial / NCT05885854
XTR003 PET Radiotracer for the Detection of Viable Myocardium
NaSingle-groupOpen-labelDiagnostic
Summary
The study was designed to explore the clinical feasibility of XTR003, a PET myocardial fatty-acid tracer, for the detection of viable myocardium in patients with ischemic heart disease (IHD).
Timeline
- Start
- 2021-12-15
- Primary completion
- 2023-03-04
- Completion
- 2023-03-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XTR003 | Diagnostic / imaging agent | 222 mbq | Intravenous |
| Subject | XTR003 | Diagnostic / imaging agent | 296 mbq | Intravenous |
| Background | 18F-FDG | Diagnostic / imaging agent | 74 mbq | Intravenous |
| Background | 18F-FDG | Diagnostic / imaging agent | 111 mbq | Intravenous |